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http://dx.doi.org/10.1016/j.jmii.2013Background: Different yeast species have different susceptibilities to commonly prescribed
antifungal drugs. Thus, it is important to accurately determine the species of pathogenic
yeasts, especially when more than one species are in a specimen.
Methods: Clinically significant yeast isolates were collected via the Taiwan Surveillance of
Antimicrobial Resistance of Yeasts from July to September in 2010. The identifications of iso-
lates were assessed in the core laboratory at the National Health Research Institutes.
Results: Of the 1127 isolates recovered, 1088 were of Candida genus, accounting for 96.53% of
the total isolates, followed by Cryptococcus (15, 1.33%), Trichosporon (12, 1.06%), Kodamaea
(4, 0.35%), Pichia (4, 0.35%), and three others. In all, 38 out of 1116 (3.4%) specimens had
mixed yeast cultures. One ascites specimen had three species, Candida albicans, Candida
glabrata, and Candida tropicalis. In the remaining 37 specimens, 16 had a combination of C.
albicans and C. glabrata, eight C. albicans and C. tropicalis, five C. glabrata and C. tropicalis,
three Candida krusei and C. tropicalis, and five with different combinations.
Conclusion: The high prevalence of cultures with mixed yeasts may be an emerging issue.
Thus, to determine mixed yeast cultures in the same specimen, we highly recommend CHRO-
Magar Candida medium to culture yeast isolates directly from the specimen.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Road, Zhunan Town, Miaoli
H.-J. Lo).
an Society of Microbiology. Publ
.01.001Introduction
Due to the increased size of the populations at risk, the
prevalence of yeast nosocomial infections has increased in
the past decades. In the United States, yeast infectionsished by Elsevier Taiwan LLC. All rights reserved.
340 Y.-L. Yang et al.rank as the fourth most common cause of nosocomial
bloodstream infection.1,2 In Taiwan, the prevalence of
nosocomial candidemia increased 27-fold from 1981
through 1993.3,4 Candida species are the most frequently
isolated fungal pathogens causing morbidity and mortality
in seriously immunocompromised hosts. Although Candida
albicans is still the most prominent cause of candidemia,
the prevalence of non-C. albicans yeast species has
increased.5e8
Candida krusei, Candida glabrata, and Candida tropi-
calis are less susceptible to fluconazole than other Candida
species.8e14 Candida lusitaniae is relatively resistant to
amphotericin B.15 Accurate identification to the species
level is therefore crucial for clinical management, since
different species have various degrees of susceptibility to
common antifungal drugs.
Recently, we reported that among healthy volunteers,
5% had yeast colonization in oral cavities and 6.1% of those
incidences were by multiple species.16 Furthermore, we
have also found that there has been an increase in the
number of HIV-infected outpatients colonized by more than
one species (from 7.9% before 2002 to 19.9% in 2005 in a
Medical center in northern Taiwan and 18.7% and 20.4% in
2009 in a Medical center and a regional hospital, respec-
tively, in southern Taiwan).17e19 In the present study, we
characterized isolates collected in the Taiwan Surveillance
of Antimicrobial Resistance of Yeasts (TSARY) in 2010. The
data indicated that mixed yeast colonization is an emerging
issue.
Materials and methods
Organisms and media
From the 23 hospitals participating in TSARY, yeast isolates
were collected according to procedures reported in pre-
vious studies14,20 from July 1 to September 30, 2010. Each
hospital was asked to submit all yeast pathogens from
sterile sites and the first 10 C. albicans and 40 non-C.
albicans yeast isolates from non-sterile sites to the core
laboratory at National Health Research Institutes (NHRI).
Due to the collection criteria, the percentage of C. albicans
from different sources was not calculated. In principle,
only one isolate was accepted from each specimen. Nev-
ertheless, when there were multiple species isolated from
one specimen, one isolate from each species was analyzed.
All the collected isolates were stored at 70C in vials
containing 50% glycerol.
Identification
Primary identification of the isolates was performed by the
contributing TSARY hospitals. Then, the results were re-
assessed in the laboratory at the NHRI. All isolates identi-
fied as C. albicans by the TSARY hospitals were subjected to
germ tube assay in media containing 10% fetal bovine serum
(GibcoBRL, US-628531, Gel Company, CA, USA) at 37C for
3e4 hours. The germ tube-positive isolates that failed to
grow at 42C were further analyzed by sequencing riboso-
mal DNA (rDNA).21 All isolates identified as non-C. albicans
yeasts by the TSARY hospitals were subjected to VITEK 2(bioMe´rieux, Marcy l’Etoile, France). Cells in the vials were
streaked onto CHROMagar Candida medium (CHROMagar,
Paris, France) and the sequences of the rDNA were used for
identification when one of the followings occurred: the
identification probability of the VITEK 2 (bioMe´rieux, Marcy
l’Etoile, France) was less than 85%; the identification of an
organism was inconsistent between the hospital and the
NHRI laboratories; uncommon species were reported; and
potential mixed yeast cultures were observed during the
germ tube assay. The internal transcribed spacer (ITS)
region was amplified by the primers ITS1, 50-TCCGTAGGT-
GAACCTGCGG-30, and ITS4 50-TCCTCCGCTTATTGATATGC-30
and/or the D1/D2 region of rDNA was amplified by the
primers NL1 50-GCATATCAATAAGCGGAGGAAAAG-30 and NL4
50-GGTCCGTGTTTCAAGACGG-30.21Database and analysis
The database for this study contained the characteristic
information of each submitted isolate: hospital origin,
location and type of the hospital, identification and source
of the isolate. The procedure for yeast identification used
by each hospital was also collected. The statistical sig-
nificance of the differences in frequencies and proportions
was determined using the chi-square test with Mantel-
Haenszel correction.Results
Distribution of body sites
The mean number of isolates collected from the hospitals
participating in the TSARY was 49 (ranging from 8 to 100)
per hospital. The distribution of the 1127 isolates in dif-
ferent body sites is shown in Table 1. Among 34 different
body sites, urine (44.3%) was the most common source of
yeast clinical isolates, followed by blood (19.8%), sputum
(13.1%), catheter tip (4.8%), wound (3.7%), ascites (2.9%),
pus (2.7%), bronchial washing (2%), and 23 other different
body sites (6.7%).Distribution of species
Candida was the most common genus found, accounting for
96.53% (1088/1127) of the total isolates, followed by
Cryptococcus (15, 1.33%), Trichosporon (12, 1.06%), Koda-
maea (4, 0.35%), Pichia (4, 0.35%), and one each of Rho-
dosporidium, Rhodotorula, and Sterigmatomyces. Among
the 223 isolates recovered from blood, C. albicans (103,
46.2%) was the most common species, followed by C. tro-
picalis (41, 18.4%), C. parapsilosis (35, 15.7%), C. glabrata
(22, 9.8%), Cryptococcus neoformans (8, 3.6%), C. krusei (2,
0.9%) and 10 other species (12, 5.4%), see Table 1. Although
the prevalence of C. albicans was underestimated due to
the collection criteria, it was still the most common species
among the 1127 isolates collected in the present study (423
isolates, 37.6%). C. tropicalis (270, 24%) and C. glabrata
(262, 23.2%) were the two major non-C. albicans yeast
species, followed by C. parapsilosis (87, 7.7%), C. krusei
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Mixed yeast cultures 341(18, 1.6%), C. neoformans (15, 1.3%), and other species (52,
4.6%), see Table 1.
Mixed yeast cultures
Since we asked the hospitals to collect the first 10
C. albicans and 40 non-C. albicans yeast isolates from non-
sterile sites, there is a possibility that the specimens in the
vials just represented part of those cultured in the hospital
laboratories. Thus, the rate (38/1116, 3.4%) of mixed yeast
cultures in the present study is most likely underestimated.
Among the 38 specimens containing mixed yeast cultures,
16 were from urine, 13 from sputum, two from ascites, two
from blood, one each from bronchial washing, catheter tip,
nail, skin, and pus (Table 2). C. albicans appeared to be the
most common species co-recovered with others, accounting
for 73.7% of the cases, followed by C. glabrata (57.9%) and
C. tropicalis (44.7%). These three species were co-
recovered from one ascites specimen. Furthermore, 16
out of the remaining 37 specimens had a combination of
C. albicans and C. glabrata.
Methods of identification
Different participating hospitals applied different combi-
nations of methods for yeast identification in the present
study. CHROMagar Candida medium (52.2%) was the most
frequently used method by the 23 participating hospitals,
followed by germ tube assay (47.8%), cornmeal agar
(43.5%), ID20C (bioMe´rieux, Marcy l’Etoile, France) (30.4%),
ID32C (bioMe´rieux, Marcy l’Etoile, France) (21.7%), VITEK 2
(17.4%), VITEK Yeast Biochemical Card (bioMe´rieux, Marcy
l’Etoile, France) (8.7%), the assimilation method (8.7%),
eosin-methylene blue (4.3%), Gram staining (4.3%), micro-
scan (Siemens Healthcare Diagnostics, West Sacramento,
CA, USA) (4.3%), and rapid yeast (Innovative Diagnostic
Systems, Norcross, GA, USA) (4.3%).
Even though we requested the participating hospitals
keep only one species in an individual vial, 18 of the 38
mixed yeast cultures were not identified by the hospitals.
Four hospitals contributed one vial containing mixed yeast
cultures, two contributed two such vials, one hospital
contributed four and another hospital six such vials. The
majority of the vials (12/18) were contributed by hospitals
using methods other than the CHROMagar Candida medium
one.
In general, on CHROMagar Candida medium, C. albicans
colonies were green, C. glabrata were pink to dark purple,
C. krusei fuzzy rose with white edges, C. parapsilosis
white, and C. tropicalis steel blue accompanied by purple
pigment diffusion into the surrounding agar (Fig. 1A). When
the cells from the 18 vials containing mixed yeast culture
were streaked onto CHROMagar Candida medium in the
NHRI laboratory, 16 had colonies in two different colors.
The combination of C. albicans and C. glabrata (Fig. 1A
aej), C. krusei and C. tropicalis (Fig. 1A oep), C. glabrata
and C. tropicalis (Fig. 1A q), as well as C. albicans and
C. parapsilosis (Fig. 1A r), could be distinguished when the
cells were streaked onto CHROMagar Candida medium.
However, under this condition, C. albicans from two vials
containing the combination of C. albicans and C. tropicalis
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342 Y.-L. Yang et al.failed to show up (Fig. 1A k and l). When streaking more
cells (one vial per agar plate) from the oYM100104 and
oYM100109 vials onto CHROMagar Candida medium, we
were able to find several green colonies (arrows) of C.
albicans from the oYM100104 vial (Fig. 2A) but not from the
oYM100109 (Fig. 2B). When the mixed yeast cells were
patched onto CHROMagar Candida medium (Fig. 1B), only
the color of the dominant species would show up.
Discussion
The distribution of species in the present study was similar
to those in previous TSARYs.12,14,20 With the exception of
blood, the distributions of species found at various body
sites in the present study were not significantly different
from those in previous TSARY surveys.14,20,22 The reason
that the proportion of isolates from blood in the present
study (223/1127) was higher than those in the 2002 (130/
945 pZ 0.0003) and 2006 TSARY (160/1015 pZ 0.02) needs
further investigation.
Among the 38 specimens containing mixed yeast cul-
tures, 17 had a combination of C. albicans and C. glabrata.
Since the clinical treatments for infections caused by these
two species may be different,8,11,23 it is important to
accurately differentiate these two species, especially when
they are present in the same specimen.
There are some limitations of CHROMagar Candida
medium. For example, when the ratio of two species was
significantly different, the medium failed to detect the
minority (Figs. 1A k and l, and 2B). The medium is not
capable of detecting mixed yeast cultures in the same
specimen if the cells were patched onto it (Fig. 1B). The
fact that in the present study, the hospital using only
CHROMagar Candida medium for yeast identification mis-
identified C. parapsilosis as C. glabrata demonstrates that
CHROMagar Candida medium provides presumptive but not
definite identification of yeast species. Despite the limi-
tations, CHROMagar Candida is still a helpful tool in facili-
tating the recognition of mixed yeast cultures.24
Application of CHROMagar Candida medium to culture
yeast isolates directly from the specimen is therefore highly
recommended, particularly the specimens from patients
who did not respond well to the treatment or the specimens
from the sterile sites. The most critical point is that hos-
pital technologists should be aware of the increasing pos-
sibility that one patient may be infected by more than one
fungal species.
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